menu
    • menu

    Company profile for Pharnext

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pharnext is a biopharmaceutical company at an advanced stage of development, a leader in combinatorial medicine, developing new therapies for diseases that remain untreated. Pharnext is the pioneer of a new paradigm of drug development: PLEOTHERAPY ™ .

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharnextFrance Flag
    Country
    Country
    France
    Address
    Address
    11 rue René Jacques 92130 Issy-les-Moulineaux
    Telephone
    Telephone
    +33 (0) 1 41 09 22 30
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pharnext.com/fr
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharnext blames ‘unexpected’ placebo results for phase 3 failure
    Pharnext blames ‘unexpected’ placebo results for phase 3 failure

    11 Dec 2023

    // James Waldron FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/pharnext-blames-unexpected-placebo-results-lead-neurological-drugs-phase-3-failure

    James Waldron FIERCE BIOTECH
    11 Dec 2023
    Share Share
    Pharnext ditches Alzheimer’s plans to save cash
    Pharnext ditches Alzheimer’s plans to save cash

    14 Feb 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/pharnext-ditches-alzheimers-plans-saying-more-development-would-be-too-costly

    Max Bayer FIERCE BIOTECH
    14 Feb 2023
    Share Share
    Pharnext Appoints Scott Johnson as VP, Head of Quality
    Pharnext Appoints Scott Johnson as VP, Head of Quality

    04 Jan 2023

    // ACCESSWIRE

    https://www.accesswire.com/733937/Pharnext-Strengthens-its-Senior-Leadership-Team-with-the-Appointment-of-Scott-Johnson-as-VP-Head-of-Quality

    ACCESSWIRE
    04 Jan 2023
    Share Share
    Pharnext Strengthens its Ties With Néovacs to Secure the Next Steps Development
    Pharnext Strengthens its Ties With Néovacs to Secure the Next Steps Development

    29 Dec 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/pharnext-strengthens-its-ties-with-neovacs-to-secure-the-next-steps-in-its-development/

    BIOSPACE
    29 Dec 2022
    Share Share
    Pharnext Acknowledges the Resignation of Dr. David Horn SOLOMON as CEO
    Pharnext Acknowledges the Resignation of Dr. David Horn SOLOMON as CEO

    28 Nov 2022

    // ACCESSWIRE

    https://www.accesswire.com/728953/The-Board-of-Directors-of-Pharnext-Acknowledges-the-Resignation-of-Dr-David-Horn-SOLOMON-from-his-Duties-as-Chief-Executive-Officer-and-Director-of-the-Company

    ACCESSWIRE
    28 Nov 2022
    Share Share
    Pharnext Acknowledges Resignation of Dr. David Horn SOLOMON as CEO
    Pharnext Acknowledges Resignation of Dr. David Horn SOLOMON as CEO

    28 Nov 2022

    // ACCESSWIRE

    https://www.accesswire.com/728953/The-Board-of-Directors-of-Pharnext-Acknowledges-the-Resignation-of-Dr-David-Horn-SOLOMON-from-his-Duties-as-Chief-Executive-Officer-and-Director-of-the-Company

    ACCESSWIRE
    28 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search